Chemoprevention, a novel and useful approach in experimental oncology, deals with the prevention, suppression, or inhibition of carcinogenesis using natural or synthetic entities. This study evaluated the chemopreventive potential of berberine on 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch carcinogenesis. Oral squamous cell carcinoma was developed in the buccal pouch of golden Syrian hamsters by painting with 0.5% DMBA in liquid paraffin three times a week for 14 weeks. Tumor incidence, tumor volume, tumor burden, phase I and phase II carcinogen detoxification agents, lipid peroxidation, antioxidant status, and histopathological changes were assessed in hamsters treated with DMBA alone and in DMBA+berberine-treated animals. Hundred percent tumor incidences with an imbalance in carcinogenmetabolizing enzymes and cellular redox status were observed in hamsters treated with DMBA alone. Oral administration of berberine at a dose of 75 mg/kg body weight (bw) to DMBA-treated hamsters completely prevented tumor incidence and restored the status of the above-mentioned biochemical markers. Berberine, a traditional drug from Southeast Asia, shows promising chemopreventive efficacy in hamster buccal pouch carcinogenesis.
Introduction
Cancer of the oral cavity is one of the most prevalent cancers worldwide, and incidence rates of this cancer are higher in men than in women. It accounts for 40-50% of all cancers in India, Pakistan, and Sri Lanka, and is also highly prevalent in several Southeast Asian countries. In India, cancer registries have confirmed that a high incidence of oral cancer is associated with widespread habits of betel quid chewing with tobacco, tobacco smoking, and alcohol consumption. More than 90% of cancers of the oral cavity occur in the squamous cells that line the mucosal surfaces in the mouth and throat (Curado and Hashibe, 2009; Attar et al., 2010) . Hamster buccal pouch carcinogenesis is an excellent model to study oral carcinogenesis because the development of 7,12-dimethylbenz [a] anthracene (DMBA)-induced squamous cell carcinoma in hamster buccal pouch simulates many of the histological, biochemical, and molecular alterations that occur in human oral carcinoma (Miyata et al., 2001) .
DMBA is a potent organ-specific and site-specific procarcinogen. This carcinogen should be metabolized by phase I enzymes to reactive metabolites (diol epoxides) that can covalently bind to the DNA, contributing to carcinogenesis. Reactive metabolites formed during metabolic activation of DMBA are detoxified to inactive metabolites and excreted by the action of phase II conjugating enzymes. Measurement of phase I (cytochrome P 450 and b 5 ) and phase II [glutathione-S-transferase (GST), glutathione reductase (GR) and DT-diaphorase (DTD)] detoxification enzymes could thus help assess the chemopreventive potential of the test compound (Shimada, 2006; Singh et al., 2006; Sindhu and Manoharan, 2010) .
Overproduction of reactive oxygen species (ROS) during DMBA metabolism propagates tissue injury by initiating lipid peroxidation, which causes damage to proteins, lipids, and DNA (Blair, 2008) . ROS can cause impairment in the structure and the functions of a biomembrane if they are generated excessively. Cells have sophisticated enzymatic and nonenzymatic antioxidant systems to scavenge these radicals (Grover et al., 2009) . Oxidative stress, an imbalance in the oxidant and antioxidant defense systems, has been implicated in the pathogenesis of several disorders including cancer. Overproduction of ROS has been shown in betel quid chewers and oral cancer patients (Wilms et al., 2005; Siow et al., 2011) .
Despite the improvements in medical technology and therapeutic approaches, the 5-year survival rate of oral cancer patients has not improved over the last four to five decades and is still at 50%. Chemoprevention, a promising and alternative approach in experimental oncology, deals with the inhibition, suppression, and prevention of cancer using natural and synthetic entities (Breimer, 1990; Sengupta and Das, 1999; Hail et al., 2008; Shim et al., 2011) . Berberine ( Fig. 1) is an isoquinoline alkaloid commonly used in India, China, and other countries as a traditional drug. It is widely present in the plant kingdom: Berberidaceae, Ranunculaceae, and Papaveraceae (Khan et al., 2010) . Berberine has been shown to possess antibacterial (Samosorn et al., 2009) , antioxidative (Shirwaikar et al., 2006) , anti-inflammatory (Lu et al., 2011) , and anticarcinogenic activity in various cancer cells both in vitro and in vivo (Letasiová et al., 2006; Sun et al., 2009; Tang et al., 2009) . Ho et al. 2009 demonstrated that berberine decreased the percentage of human SCC-4 tongue cancer viable cells in a dose-dependent manner. The anticancer effect of berberine has been well documented in many types of cancer, but the mechanisms behind these actions need to be elucidated. Previous studies from our laboratory reported that berberine has a potent anticlastogenic effect against DMBA-induced clastogenesis in experimental hamsters (Sindhu and Manoharan, 2010) . To the best of our knowledge, there was no scientific evidence for the chemopreventive potential of berberine during DMBAinduced hamster buccal pouch carcinogenesis. This study was thus designed to focus the same effect of berberine during DMBA-induced oral carcinogenesis in hamsters, by monitoring tumor incidence, tumor burden, and volume, and by analyzing the status of lipid peroxidation, antioxidants, and phase I and phase II detoxification agents.
Materials and methods

Chemicals
Berberine (Z 95% purity, CAS NO.: 633-65-8) and DMBA (95% purity, CAS NO.: 57-97-6 soluble in liquid paraffin) were purchased from Sigma Aldrich Chemical Pvt. Ltd. (Bangalore, Karnataka, India). All other chemicals used were of analytical grade, purchased from Hi-media Laboratories Pvt, Ltd., Mumbai, India.
Animals
Male golden Syrian hamsters, 8-10 weeks old, weighing 80-120 g, were purchased from the National Institute of Nutrition, Hyderabad, India, and were maintained in the Central Animal House, Rajah Muthaiah Medical College and Hospital, Annamalai University, Annamalainagar, India. The animals were housed in polypropylene cages and were provided with standard pellet diet (Amrut Laboratory Animal Feed, Mysore Feeds Limited, Bangalore, Karnataka, India) and water ad libitum. The standard pellet diet is composed of 21% protein, 5% lipids, 4% crude fiber, 8% ash, 1% calcium, 0.6% phosphorus, 3.4% glucose, 2% vitamins, and 55% nitrogen-free extract (carbohydrates). The animals were maintained under controlled conditions of temperature (27 ± 21C) and humidity (55 ± 5%) with a 12 h light/dark cycle.
Tumor induction
Hamster buccal pouch carcinogenesis was induced in golden Syrian hamsters by topical application of 0.5% DMBA in liquid paraffin three times a week for 14 weeks. The total number of tumors in each hamster buccal pouch was determined macroscopically at the time of sacrifice of the animals, and the diameter of each tumor was measured with a vernier caliper. Tumor volume was measured using the formula V ¼ 
Experimental design
The local institutional animal ethics committee (Registration number 160/1999/CPCSEA) of Annamalai University approved the experimental design. The animals were maintained following the principles and the guidelines of the ethical committee for animal care of Annamalai University in accordance with the Indian National Law on animal care and use.
Dose-dependent study
A total of 50 hamsters were categorized into five groups of 10 hamsters in each group. Group 1 hamsters served as the vehicle-treated control and were painted with liquid paraffin (vehicle) alone three times a week for 14 weeks on their left buccal pouches. Hamsters in groups 2-5 were painted with a 0.5% solution of DMBA in liquid paraffin, three times a week for 14 weeks with a number 4 painting brush, which leaves approximately 0.4 mg of DMBA with each application. Hamsters in group 2 received no further treatment. Animals in groups 3-5 were administered, using an intragastric tube, berberine dissolved in warm water at a concentration of 50, 75, and 100 mg/kg bw, respectively, three times a week on days alternate to DMBA application, starting a week before the exposure to the carcinogen and continued throughout the experimental period. The experiment was terminated at the end of 16th week, and all animals were killed by cervical dislocation. Tumor Berberine prevents oral carcinogenesis Manoharan et al. 183 incidence and tumor volume were examined in control and experimental hamsters in each group. From our preliminary experimental design, we found that doses of 75 and 100 mg/kg bw of berberine completely prevented the tumor formation in experimental hamsters as evidenced by macroscopic examination of hamster buccal pouches. The lower dose of 75 mg/kg bw of berberine was therefore used for further chemoprevention study.
Chemoprevention study
A total of 40 hamsters were categorized into four groups of 10 hamsters in each group (Fig. 2) . Group 1 animals served as control and were painted with liquid paraffin (vehicle) three times a week for 14 weeks on their left buccal pouches. Animals in groups 2 and 3 were painted with a 0.5% solution of DMBA in liquid paraffin three times per week for 14 weeks. Animals in group 2 received no other treatment. Group 3 animals were orally administered with berberine at a concentration of 75 mg/kg bw three times per week on days alternate to DMBA application, starting 1 week before the exposure to the carcinogen and continued until 1 week after the final exposure of the carcinogen. Group 4 animals received an oral administration of 75 mg/kg bw berberine alone throughout the experimental period. All animals were killed by cervical dislocation at the end of the experimental period.
Histopathological studies
Histopathological investigations were performed on buccal mucosa tissues of the control and experimental animals in each group. Tissues were fixed in 10% buffered formalin and routinely processed and embedded with paraffin; 2-3 mm sections were cut in a rotary microtome, fixed on glass slides, and stained with hematoxylin and eosin.
Biochemical analysis Sample collection
Biochemical studies were conducted on blood, liver, and buccal mucosa of the control and experimental animals in each group. Blood samples were collected into heparinized tubes. Plasma was separated by centrifugation at 1000g for 15 min. Aliquots from these preparations were used for biochemical estimations. Tissue samples from animals were washed with ice-cold saline and homogenized using the appropriate buffer [GST, 0.3 mol/l phosphate buffer, pH 6.5; GR, 0.1 mol/l phosphate buffer, pH 7.4; thiobarbituric acid reactive substances (TBARS), 0.025 mol/l Tris-HCl buffer, pH 7.5; reduced glutathione (GSH) and glutathione peroxidase (GPx), 0.4 mol/l phosphate buffer, pH 7.0; superoxide dismutase (SOD), 0.025 mol/l sodium pyrophosphate buffer, pH 8.3; catalase (CAT), 0.01 mol/l phosphate buffer, pH 7.0] in an All-glass homogenizer with a Teflon pestle (DuPont, Wilmington, Delaware, USA) and used for biochemical estimations.
The protein content was determined by the method of Lowry et al. (1951) . The levels of cytochrome P 450 and b 5 in the liver and buccal mucosa were determined according to the method of Omura and Sato (1964) . DTD activity was assayed as described by Ernster (1967) . The activity of GST in the liver and buccal mucosa was assayed by the method of Habig et al. (1974) . GR activity in the liver was assayed by the method of Carlberg and Mannervik (1985) .
Lipid peroxidation was estimated as evidenced by the formation of TBARS. TBARS in plasma and tissues were assayed by the methods of Yagi (1987) and (Ohkawa et al. (1979) respectively. SOD, GPx, and CAT activities were assessed by the methods of Kakkar et al. (1984) , Rotruck et al. (1973) , and Sinha (1972) respectively. GSH levels in the plasma, buccal mucosa, and liver were determined by the method of Beutler and Kelly (1963) . The oxidized glutathione level in the buccal mucosa was determined by the method of Tietze (1969) . The vitamin E level in the plasma and buccal mucosa was determined using the methods of Desai (1984) and Palan et al. (1991) respectively.
Statistical analysis
The data are expressed as mean ± SD. Statistical comparisons were performed by one-way analysis of variance, followed by Duncan's multiple range test using SPSS version 12.0 for windows (SPSS Inc., Chicago, Illinois, USA; http://www.spss.com). The results were considered statistically significant if the P values were 0.05 or less. Table 1 shows the tumor incidence, tumor volume, and tumor burden of the control and the experimental hamsters in each group. We noticed 100% tumor incidence with large exophytic oral tumors in the left buccal pouches of hamsters treated with DMBA alone (Group 2). Oral administration of berberine at a dose of 75 mg/kg bw to DMBA-treated hamsters (Group 3) completely prevented the tumor incidence, tumor volume, and tumor burden. No tumors were observed in control hamsters painted with liquid paraffin alone (Group 1). The gross appearance of oral squamous cell carcinoma noticed in a hamster treated with DMBA alone is shown in Fig. 3 . Histological studies have shown that the buccal pouches from hamsters treated with DMBA alone revealed severe keratosis, hyperplasia, dysplasia, and well-differentiated squamous cell carcinoma (Fig. 4b) . Mild hyperplasia and mild dysplasia were noticed in DMBA+berberine-treated hamsters (Fig. 4c) . Hamsters administered berberine alone and controls showed normal cellular architecture with no signs of cell proliferation ( Fig. 4a and d ). Figure 5 shows the status of TBARS and enzymatic (SOD, CAT, and GPx) antioxidants in the plasma of control and experimental hamsters in each group. An increase in TBARS and a decrease in antioxidant status were noticed in the plasma of hamsters treated with DMBA alone (Group 2). Oral administration of berberine at a dose of 75 mg/kg bw to DMBA-treated hamsters (Group 3) brought back the concentration of TBARS and antioxidants to a near-normal range. No significant differences in the TBARS and the antioxidant status were noticed in hamsters treated with berberine alone (Group 4) as compared with control hamsters (Group 1). Figure 6 shows the status of nonenzymatic antioxidants (vitamin E, GSH) in the plasma and buccal mucosa of control and experimental hamsters in each group. The levels of vitamin E and GSH decreased in the plasma, whereas they increased in the buccal mucosa of hamsters treated with DMBA alone (Group 2). Oral administration of berberine at a dose of 75 mg/kg bw to DMBA-treated hamsters (Group 3) brought back the status of vitamin E and GSH to the near-normal range. No significant differences in vitamin E and glutathione levels were noticed in hamsters treated with berberine alone (Group 4) as compared with control hamsters (Group 1). Figure 7 shows the status of TBARS and antioxidants in the buccal mucosa of control and experimental hamsters in each group. Hamsters treated with DMBA alone (Group 3) showed a decreased TBARS level and a disrupted antioxidant Table 1 Incidence of oral neoplasia in control and experimental animals in each group (n = 10) Table 2 shows the activities of phase I (cytochromes P 450 and b 5 ) and phase II (GSH, GST, GR, and DTD) detoxification enzymes and glutathione levels in the liver of control and experimental animals in each group. The activities of phase I enzymes were increased, whereas phase II detoxification enzymes were significantly decreased in hamsters treated with DMBA alone (Group 2) as compared with control hamsters. Oral administration of berberine to DMBA-treated hamsters (Group 3) significantly restored activities of the detoxification agents to the near-normal range. Berberine alone-treated hamsters (Group 4) showed no significant difference in the status of detoxification agents as compared with control hamsters (Group 1).
Results
The status of phase I and phase II enzymes in the buccal mucosa of control and experimental hamsters in each group is shown in Table 3 . In the buccal mucosa, the 
Status of plasma and buccal mucosa nonenzymatic antioxidants. Values are expressed as mean ± SD for 10 animals in each group. Values that do not share a common superscript letter in the same column differ significantly at P less than 0.05. activities of phase I (cytochromes P 450 and b 5 ) and phase II GST, GR, and GSH were significantly increased, whereas the GSSG content was decreased in hamsters treated with DMBA alone (Group 2) as compared with control hamsters. Oral administration of berberine to DMBA-treated hamsters (Group 3) significantly restored the activities of phase I and phase II enzymes and GSH to the near-normal range. Berberine alone-treated hamsters (Group 4) showed no significant difference in the status of phase I and phase II enzymes as compared with control hamsters (Group 1).
Discussion
In recent years, researchers on cancer chemoprevention have made considerable efforts to identify the chemopreventive potential of pharmacologically active natural and synthetic agents (Kim et al., 2011; Rajkumar et al., 2011) . In most cases of oral cancer, the cancer is diagnosed at the advanced stages of the disease, and thus, the 5-year survival rate of these forms of cancers are still at 50% despite recent advances in the treatment (Chen et al., 2008) . DMBA-induced hamster buccal pouch carcinogenesis is the most widely accepted model of experimental oral cancer and this animal model could also help to assess the chemopreventive efficacy of the test agent before embarking on clinical trials (El-Rouby, 2011). Letchoumy et al. (2007) demonstrated the protective effect of black tea polyphenols (Polyphenon B) against genotoxicity and oxidative stress during DMBA-induced hamster buccal pouch carcinogenesis. Bhuvaneswari et al. (2003) suggested that measurement of lipid peroxidation and GSH-dependent antioxidants could be valuable in evaluating carcinogenic progression and the effects of putative chemopreventive agents in the hamster buccal pouch model. Nagini (2009) suggested that chemoprevention studies in the hamster buccal pouch model can serve as a crucial link in the potential efficacy assessment of chemopreventive agents for oral cancer prevention and therapy. Yang et al. (2008) reported that Zyflamend prevented DMBA-induced oral carcinogenesis at the post-initiation stage. Lim et al. (2009) reported that glutamine significantly prevented DMBA-induced squamous cell cancer and suggested that the chemopreventive effect of glutamine is probably due to its antioxidant and apoptotic function. Manoharan et al. (2009a Manoharan et al. ( , 2010 demonstrated the chemopreventive efficacy of curcumin, piperine, and carnosic acid during DMBA-induced hamster buccal pouch carcinogenesis. They concluded that the chemopreventive efficacy of curcumin and piperine is probably due to their antilipid peroxidative and antioxidant potential and their modulating effect on the carcinogen 188 (2008) demonstrated that ferulic acid has potent chemopreventive and antioxidant functions in DMBA-induced hamster buccal pouch carcinogenesis. Balakrishnan et al. (2010) demonstrated the protective role of curcumin and ferulic acid on DMBA-induced abnormal expression of p53 and bcl-2 proteins in the buccal mucosa of golden Syrian hamsters. Kheir et al. (2010) investigated the acute toxicity of berberine and its correlation with the blood concentration in mice. On the basis of their experimental results, they suggested that a safe dosage of berberine is 20.8 g/kg (or a berberine blood concentration of 0.168 mg/ml), whereas a toxic dosage could be at 41.6 g/kg, which corresponds to a berberine blood concentration of 0.432 mg/ml. Li et al. (2009) reported that berberine promoted the development of atherosclerosis and foam cell formation by inducing scavenger receptor-A expression in macrophages in apolipoprotein E-deficient mice. Dunnick et al. (2011) suggested that long-term administration of goldenseal root powder resulted in liver tumors in rats and mice, which may be due in part to the topoisomerase inhibition properties of berberine, a major alkaloid constituent in goldenseal, or its metabolite, berberrubine. Ito et al. (2001) and Cui et al. (2006) suggested that isoquinoline alkaloids including protoberberines may be potentially valuable cancer chemopreventive agents and anti-tumor promoters. Thirupurasundari et al. (2009) suggested that berberine prevented the appearance of malignant morphology and ultrastructural changes by the induction of apoptosis and antioxidant defense systems in azoxymethane-induced colon cancer in rats.
This study investigated the chemopreventive potential of berberine in DMBA-induced oral carcinogenesis. Hamsters treated with DMBA alone for 14 weeks showed marked histopathological and biochemical abnormalities as compared with control hamsters. We noticed 100% tumor formation, which was histopathologically confirmed as well-differentiated squamous cell carcinoma in the hamsters treated with DMBA alone. The severity of precancerous lesions such as hyperplasia, hyperkeratosis, and dysplasia was assessed by an oral pathologist from Annamalai University.
We noticed severe hyperplasia, hyperkeratosis, and dysplasia in hamsters treated with DMBA alone. Oral administration of berberine at a dose of 75 mg/kg bw completely prevented the development of tumors in the buccal mucosa of DMBA-treated hamsters. We however noticed mild hyperplasia and dysplasia in DMBA+ berberine-treated animals, which was probably due to the mechanical irritation of the brush for 14 weeks. These results suggest that berberine suppressed abnormal proliferation occurring during DMBA-induced oral carcinogenesis, as evidenced by complete prevention of tumor formation in the buccal mucosa of DMBA-treated hamsters.
Phase I biotransformation enzymes are involved in the metabolic activation of carcinogens, whereas phase II enzymes are involved in the detoxification of carcinogenic agents (Szaefer et al., 2011) . Experimental studies demonstrated that the activity of phase I enzymes was inhibited by phytochemicals to curb the biotransformation of DMBA (Krajka-Kuźniak et al., 2004 , 2009 . A large number of phytoconstituents from medicinal plants have been shown to be inhibitors of phase I enzymes (Wang and Leung, 2010) . Studies have reported that the activities of phase I and II enzymes were significantly altered during DMBA-induced oral carcinogenesis (Vinothini et al., 2009) . Our results are in line with these findings. Increased activities of phase I enzymes and decreased activities of phase II enzymes in the liver of hamsters treated with DMBA suggest that the ultimate carcinogenic metabolite of DMBA, dihydrodiolepoxide, was accumulated and not excreted during DMBAinduced oral carcinogenesis. Decreased activity of GST and GR in the liver of DMBA-treated hamsters is probably due to the low availability of its substrate glutathione, as it plays a profound role in the detoxification of carcinogenic metabolites and scavenging of ROS.
Increased activities of phase I and II enzymes in the buccal mucosa of hamsters treated with DMBA alone suggest that the activities of these enzymes were impaired because of repeated insult with the carcinogen DMBA for 14 weeks. Oral administration of berberine to DMBA-treated hamsters restored the status of phase I and phase II enzymes in the liver and buccal mucosa, which suggests that berberine might have played a crucial role in the detoxification of the carcinogens, by aiding in either the inhibition of the metabolic activation of DMBA or the stimulation of excretion of the carcinogenic metabolite.
Overproduction of ROS and their improper removal leads to several pathological conditions including cancer (Aqil et al., 2006) . ROS are involved in invasion and metastatic processes of carcinogenesis (Tanaka et al., 2011) . Low availability of polyunsaturated fatty acids, a substrate of lipid peroxidation, has been reported in oral carcinogenesis . Rapidly proliferating tumor cells have a low content of lipid peroxidation byproducts (Kolanjiappan et al., 2003) . Diminished lipid peroxidation with disturbances in the antioxidant status has been well documented in both human and experimental oral carcinogenesis (Mohan et al., 2008) . Our results corroborate these observations. A decreased level of TBARS in oral tumor tissues is probably due to the low availability of polyunsaturated fatty acids or rapid cell proliferation occurring in oral carcinogenesis. Increased levels of GSH and enhanced activity of GPx in tumor tissues suggest their regulatory effects on cell proliferation. Decreased activities of SOD and CAT have been reported in the Berberine prevents oral carcinogenesis Manoharan et al. 189 tumor tissues of several cancers including oral cancer (Manoharan et al., 2009b) . Our results lend credence to these observations. Antioxidants play a crucial role in the protection of human health by preventing the deleterious effects of ROS. Enzymatic and nonenzymatic antioxidants are directly involved in scavenging of ROS, and thus protect cells from ROS-mediated oxidative DNA damage . SOD catalyzes the dismutation of superoxide anion into hydrogen peroxide and molecular oxygen (Kim et al., 2011; Oberley and Buettner, 1979) . CAT catalyzes the detoxification of hydrogen peroxides to molecular oxygen and water (Fang et al., 2002) . GPx, in association with its cosubstrate GSH, protects the cell from oxidative damage by catalyzing the reduction of hydroperoxides (Husain et al., 1987) . Studies have demonstrated that bioactive constituents of natural products inhibit carcinogenic processes by decreasing free radical-mediated lipid peroxidation and enhancing the antioxidant defense mechanism (Rajkumar et al., 2011; Smith-Warner et al., 2000) .
Tumor cells sequester nutrients and antioxidants from the circulation in order to meet their nutrient demand and for their rapid growth. Lipid peroxides that are formed at the primary site could be transferred to other tissues to propagate the process of lipid peroxidation (Chang et al., 2011) . Increased levels of plasma TBARS in DMBA-treated hamsters are probably due to the accumulation of ROS or the insufficient antioxidant potential. Decreased levels of enzymatic and nonenzymatic antioxidants are due to the exhaustion of these antioxidants to scavenge excessively generated ROS in the system. Oral administration of berberine to DMBA-treated hamsters restored the status of plasma lipid peroxidation and antioxidants. Our results suggest that berberine prevented the accumulation of ROS in hamsters treated with DMBA as evidenced by the increased activities of antioxidant enzymes and the levels of nonenzymatic antioxidants.
An improvement in the antioxidant defense mechanism might have upregulated the activities of the detoxification cascade to inhibit the metabolic activation of DMBA in hamsters treated with DMBA+berberine. Berberine has been reported to have a potent and diverse antioxidant role. Berberine quenched superoxide radicals, nitric oxide (NO), and hydroxide radicals. The antilipid peroxidative effect of berberine has been documented well (Lu et al., 2011; Lee et al., 2010) . Studies have shown that berberine exhibited a strong superoxide anion radical quenching effect. Racková et al. (2004) reported that berberine prevented oxidative damage caused by ONOO -, NO, and O 2 -in vitro and increased cell viability.
Other possible mechanisms reported for the antioxidant potential of berberine include removal of oxygen, scavenging of ROS and nitrogen species or their precursors, inhibition of ROS and reactive nitrogen species, binding metal ions needed for catalysis of reactive oxygen generation, and upregulation of endogenous antioxidant defenses (Siow et al., 2011) . Our results therefore suggest that berberine attenuated DMBA-induced oxidative stress by maintaining the balance of oxidant and antioxidant status during DMBA-induced oral carcinogenesis. This study thus demonstrated the protective effect of berberine against oxidative stress in hamsters treated with DMBA.
This study has demonstrated the chemopreventive potential of berberine in DMBA-induced hamster buccal pouch carcinogenesis, and concluded that berberine has the potential to prevent or suppress early phases of oral carcinogenesis. The chemopreventive potential of berberine is probably due to its antioxidant potential and modulating effect on the detoxification cascade during DMBA-induced oral carcinogenesis. To further validate the chemopreventive efficacy of berberine, this study is extended to investigate the effect of berberine on the expression of various molecular markers that are related to oral carcinogenesis.
